AstraZeneca’s $39B Alexion buyout bears fruit, yielding late-phase win for potential blockbuster rare disease drug
AstraZeneca’s $39B Alexion buyout bears fruit, yielding late-phase win for [...]
Sesen, still reeling from FDA rejection, pulls filing for EU approval of cancer drug
Sesen, still reeling from FDA rejection, pulls filing for EU [...]
Replimune axes CMO role and CMO Pirzkall along with it
Replimune axes CMO role and CMO Pirzkall along with it [...]
Unraveling the link between migraines and protection against diabetes
Unraveling the link between migraines and protection against diabetes klahucik [...]
Bristol-backed Cardior gets $75M to run midphase antisense heart failure trial
Bristol-backed Cardior gets $75M to run midphase antisense heart failure [...]
Improving CAR-T cell therapy with more sensitive tumor identification
Improving CAR-T cell therapy with more sensitive tumor identification aliu [...]
Brii’s COVID-19 antibody slashes hospitalizations and deaths in late-phase trial, teeing it up to take on Regeneron
Brii’s COVID-19 antibody slashes hospitalizations and deaths in late-phase trial, [...]
Pfizer deal a spark for M&A, or just fuel for an empty pipeline? Analysts try to read the tea leaves
Pfizer deal a spark for M&A, or just fuel for [...]
The FDA wants more data. Stealth is filing for approval anyway
The FDA wants more data. Stealth is filing for approval [...]
BlueWillow shares early look at data on nasal anthrax vaccine
BlueWillow shares early look at data on nasal anthrax vaccine [...]